-
Takeda launches Adzynma
Adzynma is the first recombinant ADAMTS13 enzyme replacement therapy for treating Congenital Thrombotic Thrombocytopenic Purpura. -
Novo Nordisk sues 2 Florida pharmacies for allegedly selling impure weight-loss drugs
Novo Nordisk's lawsuits allege that the pharmacies' products claiming to contain the active ingredient for its in-demand weight-loss drug Wegovy were impure.